ライフサイエンスコーパス: vector-borne disease

1 t could be manipulated as a means to control vector-borne disease.

2 ts into the epidemiology and transmission of vector-borne disease.

3 to occur when weather conditions favor this vector-borne disease.

4 ed mechanism that contributes to severity of vector-borne disease.

5 pe is equally susceptible to transmission of vector-borne disease.

6 vaccine and treatment are available for this vector-borne disease.

7 cal processes that increase the emergence of vector-borne disease.

8 ically manipulated insects in the control of vector-borne diseases.

9 ion strategy against this and possibly other vector-borne diseases.

10 ms of immunity to Lyme borreliosis and other vector-borne diseases.

11 ces and may be a vaccine target against some vector-borne diseases.

12 mework based on the transmission dynamics of vector-borne diseases.

13 flies (Simuliidae) and combating associated vector-borne diseases.

14 vectors, and hence the subsequent control of vector-borne diseases.

15 enting these emerging anaphylactic and other vector-borne diseases.

16 of malaria, dengue, encephalitis, and other vector-borne diseases.

17 reproduction ratio (R(0)) exist for several vector-borne diseases.

18 in the effort to control transmission of the vector-borne diseases.

19 olution of alternative transmission modes in vector-borne diseases.

20 developing biological control strategies for vector-borne diseases.

21 of biological control agents in controlling vector-borne diseases.

22 for I. hexagonus, which has implications for vector-borne diseases.

23 a key to finding new strategies to eliminate vector-borne diseases.

24 ed guard for detecting exotic arthropods and vector-borne diseases.

25 s can help protect children from significant vector-borne diseases.

26 nship between risk factors and prevalence of vector-borne diseases.

27 ene transfer technologies for the control of vector-borne diseases.

28 Yellow fever is a vector-borne disease affecting humans and non-human prim

29 n grid can influence the spatial dynamics of vector borne disease and should be considered when desig

30 to a reevaluation of control strategies for vector-borne disease and be applicable to other disease

31 the field hold great promise for controlling vector-borne diseases and agricultural pests.

32 heoretical underpinning of our struggle with vector-borne disease, and still our strongest tool, rema

33 and droughts, changes in the distribution of vector-borne diseases, and effects on the risk of disast

34 Mosquito ecology and the transmission of vector-borne disease are influenced by multiple environm

35 Emerging vector-borne diseases are an important issue in global h

36 Vector-borne diseases are common in nature and can have

37 , control, and evolution of communicable and vector-borne diseases are intimately connected to the jo

38 Vector-borne diseases are on the rise globally.

39 Vector-borne diseases are particularly responsive to cha

40 In Ecuador, vector-borne diseases are present from coastal and Amazo

41 With increasing urbanization vector-borne diseases are quickly developing in cities,

42 rch considering impacts of climate change on vector-borne diseases assumes that all populations of a

43 threshold index for epidemicity to models of vector-borne disease because these models have a long hi

44 Vector-borne diseases can be contracted by exposure to c

45 Emerging and resurging vector-borne diseases cause significant morbidity and mo

46 Leishmaniasis, a vector-borne disease caused by obligate intramacrophage

47 es including filariasis in eastern Burma and vector-borne diseases (Chagas' disease, leishmaniasis, a

48 expanding the burden of disease from certain vector-borne diseases, climate change represents a major

49 However, the use of DDT to control vector-borne diseases continues in developing countries.

50 Given the large potential benefit to vector-borne disease control, research into the developm

51 proposed program is generally applicable to vector-borne disease control.

52 With the recent resurgence of vector-borne diseases due to urbanization and developmen

53 ented provide a framework to explore spatial vector-borne disease dynamics and control in heterogeneo

54 We develop spatial models of vector-borne disease dynamics on a network of patches to

55 Vector-borne diseases exact a high public health burden

56 For many vector borne diseases, however, two or more vector speci

57 miological shifts with changing climate: (i) vector-borne diseases, (ii) pneumonia and influenza, (ii

58 irds and humans, has emerged as the dominant vector borne disease in North America.

59 ry, an unprecedented change in the status of vector-borne disease in Europe has occurred.

60 mental variables, in studies of peridomestic vector-borne disease in human populations.

61 currently available, is a commonly reported vector-borne disease in North America and Europe.

62 elia burgdorferi, has become the most common vector-borne disease in North America over the last thre

63 Lyme disease is the most prevalent vector-borne disease in North America, and both the annu

64 Lyme disease is the most common vector-borne disease in the United States.

65 a burgdorferi, is the most commonly reported vector-borne disease in the United States.

66 d host persistence in the face of introduced vector-borne diseases in Hawaii, where introduced avian

67 g mechanism for the spread of many important vector-borne diseases in humans.

68 an urgent need to understand the dynamics of vector-borne diseases in rapidly changing urban environm

69 this Review, we summarise the risks posed by vector-borne diseases in the present and the future from

70 t compelling emerging bacterial zoonotic and vector-borne diseases in the United States are Lyme dise

71 n half of the world population is at risk of vector-borne diseases including dengue fever, chikunguny

72 climate models shed light upon the spread of vector-borne disease, including Lyme disease in North Am

73 egies can by themselves suffice for managing vector-borne diseases, integrating these approaches beco

74 to aid in controlling the growing burden of vector-borne disease is population replacement, in which

75 The transmission of vector-borne diseases is dependent upon the ability of t

76 trategy for the control of malaria and other vector-borne diseases is the introduction into wild vect

77 females, can be used in a program to control vector-borne diseases it is essential to understand thei

78 Many vector-borne diseases lack effective vaccines and medica

79 Rift Valley fever (RVF) is a zoonotic and vector-borne disease, mainly present in Africa, which re

80 The role of host movement in the spread of vector-borne diseases of livestock has been little studi

81 work is flexible and can be adapted to other vector-borne diseases of livestock.

82 invasions may help ameliorate the burden of vector-borne diseases on human health.

83 In vector-borne diseases, pathogen transmission rate is str

84 Leishmaniasis, a vector-borne disease ranked among the six most important

85 s part of an applied transgenic strategy for vector-borne disease reduction.

86 ide a new set of armaments in the battle for vector-borne disease reduction.

87 ENSO was associated more with vector-borne disease [relative risk (RR) 2.96, 95% confi

88 Improved control of vector-borne diseases requires an understanding of the m

89 The emergence of new vector-borne diseases requires new methods of vector con

90 riod of substantial scientific growth in the vector-borne disease research community.

91 ate, climate-change adaptation strategies on vector-borne disease risk in the UK.

92 aribbean emphasise the need to assess future vector-borne disease risks and prepare contingencies for

93 interplay between human immunocompetence and vector-borne disease risks in a warmer world.

94 o disease vectors, we argue that research on vector-borne diseases should be cross-scale and include

95 Vector-borne disease specialists have traditionally assu

96 Vector-borne diseases such as malaria and dengue fever c

97 interventions against the ongoing burden of vector-borne diseases such as malaria and dengue.

98 ay be particularly useful for the control of vector-borne diseases such as malaria.

99 are also emerging with the control of 'old' vector-borne diseases such as malaria.

100 itoes and are of extreme interest to control vector-borne diseases such as malaria.

101 ction is particularly crucial for studies of vector-borne disease, such as Lyme disease, for which ri

102 progress in control of these waterborne and vector-borne diseases, such as guinea worm, schistosomia

103 been employed for studies on the control of vector-borne diseases, such as malaria.

104 The leishmaniases are vector-borne diseases that have a broad global distribut

105 ize that to fully understand transmission of vector-borne diseases the interaction between the parasi

106 osts or parasites are mobile, for example in vector-borne diseases, the spatial location of infection

107 ing areas, as well as their direct effect on vector-borne disease transmission are needed to evaluate

108 ts demonstrate the dynamics of post-disaster vector-borne disease transmission, in the context of con

109 nts an important new approach for monitoring vector-borne disease under climate change.

110 the distribution of 14 vectors of the above vector-borne diseases under present-day and future clima

111 Vector-borne diseases (VBD) challenge our understanding

112 Vector-borne diseases (VBDs) are difficult to prevent an

113 ng global threat of emerging and re-emerging vector-borne diseases (VBDs) poses a serious health prob

114 Vector-borne diseases (VBDs) such as malaria, dengue, an

115 0.87) in the Western region; the increase in vector-borne disease was attributable to increased risk

116 virus (DENV) is the agent of the most common vector-borne disease worldwide.

117 Malaria is arguably the most serious vector-borne disease worldwide.